AstraZeneca CEO discusses leaving London for US and Japan facing new, bigger tariff - Stock markets updates and business news ...

President Trump’s threat of a 35% tariff on imports from Japan weighed on the Nikkei 225, which stands about 0.4% lower. The ...

Gilt yields spike on Reeves exit speculation and AstraZeneca CEO discusses leaving London - Stock markets updates and ...

AstraZeneca PLC (NASDAQ:AZN) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company announced ...

Top riser on the FTSE 350 today is B&M European Value Retail SA (LSE:BME) after analysts at RBC Capital Markets joined those ...

The endometriosis market is expected to grow from $938.0m in 2024 to $2.5 billion in 2034, at a compound annual growth rate ...

AstraZeneca secured a fast approval of lung and breast cancer drugs with usually sluggish Japanese regulators, just months after scoring similar approvals in the West. The Japanese Ministry of ...

Learn about June 2025’s top biotech deals, featuring major collaborations in small molecules, protein therapeutics, and ...

One of the most read (and recommended) books on investing is Benjamin Graham’s The Intelligent Investor. Among many others, ...

When Donald Trump unveiled his “One Big Beautiful Bill” last month, all the focus was on how the president’s trillions of tax ...

AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company's story, from its creation as a merger of two equals, to its recent major ...

The biggest fallers on the FTSE 100 were ConvaTec, down 16.4p at 272.0p, Rolls-Royce, down 28.0p at 939.6p, Babcock ...